Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Purchases Mass Spec Joint Venture from Danaher's AB Sciex

Premium

PerkinElmer announced today that it has acquired the remaining half of its mass spectrometry joint venture from Danaher's AB Sciex for an undisclosed amount.

The JV covers inductively coupled plasma mass specs. PerkinElmer now has full ownership of its ICP-MS product line. In a statement, the company said that having sole ownership of the business "will help to ensure the continued success of this technology with a dedicated and fully integrated approach throughout the entire value chain, including R&D, manufacturing, sales, and service."

The JV was originally forged by PerkinElmer and MDS Sciex. When MDS acquired Molecular Devices in 2007 and merged it with the Sciex business to form MDS Analytical Technologies, the Analytical Technologies group assumed the JV.

In September, MDS entered into a deal to sell Analytical Technologies and its half of another mass spec joint venture with Life Technologies Applied Biosystems to Danaher for $650 million.

In December, PerkinElmer filed legal action to block the sale of MDS' half of their JV to Danaher. The JV required MDS to get PerkinElmer's approval on such a deal, which it did not provide. In January, though, PerkinElmer and MDS reached a settlement, freeing MDS to sell Analytical Technologies and its half of the JV to Danaher [See PM 01/29/10].

The sale was completed earlier this month and the JV was assumed by AB Sciex, formed to house the mass spec assets Danaher acquired from MDS and Life Tech. An AB Sciex spokesman referred a request for comment to Danaher, which did not respond.

John Roush, president of Environmental Health for PerkinElmer, said the deal "will reinforce our market leadership while further demonstrating our commitment to the ICP-MS product line and the sustained development of this critical technology."

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.